Literature DB >> 15956286

The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure.

Kathleen Freson1, Rita De Vos, Christine Wittevrongel, Chantal Thys, Johan Defoor, Luc Vanhees, Jos Vermylen, Kathelijne Peerlinck, Chris Van Geet.   

Abstract

The discoid form of platelets is maintained by a marginal band of tightly coiled microtubules. beta1-tubulin is the major isoform within platelet and megakaryocyte microtubules. In 24.2% of 33 unrelated inherited macrothrombocytopenia patients and in 10.6% of 272 subjects of a healthy population a P for Q substitution in beta1-tubulin was found in the highly conserved residue 43. Heterozygous carriers of the Q43P variant showed a reduced platelet protein beta1-tubulin expression. Transfection of green fluorescent protein (GFP)-tagged Q43P beta1-tubulin in megakaryocytic MEG01 cells resulted in a disturbed tubulin organization. Electron microscopy revealed enlarged spherocytic platelets with a disturbed marginal band and organelle-free zones. In addition, platelets with the Q43P beta1-tubulin variant had reduced adenosine triphosphate (ATP) secretion, thrombin receptor activating peptide (TRAP)-induced aggregation and collagen adhesion. The prevalence of the Q43P beta1-tubulin variant was also 2 times higher (odds ratio, [OR] = 2.1;95% confidence interval [CI], 1.22-3.59) among control subjects than among patients with cardiovascular disease (10.4% versus 5.2%, P < .001). By analyzing this protective factor in men and women separately, this association was only found in men. This study thus presents the functional consequences of the platelet Q43P beta1-tubulin substitution that is frequent in the healthy population and may protect men against arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956286     DOI: 10.1182/blood-2005-02-0723

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation).

Authors:  Patrizia Noris; Silverio Perrotta; Roberta Bottega; Alessandro Pecci; Federica Melazzini; Elisa Civaschi; Sabina Russo; Silvana Magrin; Giuseppe Loffredo; Veronica Di Salvo; Giovanna Russo; Maddalena Casale; Daniela De Rocco; Claudio Grignani; Marco Cattaneo; Carlo Baronci; Alfredo Dragani; Veronica Albano; Momcilo Jankovic; Saverio Scianguetta; Anna Savoia; Carlo L Balduini
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 2.  Does size matter in platelet production?

Authors:  Jonathan N Thon; Joseph E Italiano
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

Review 3.  The biogenesis of platelets from megakaryocyte proplatelets.

Authors:  Sunita R Patel; John H Hartwig; Joseph E Italiano
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.

Authors:  Giulia Romano; Mario Acunzo; Michela Garofalo; Gianpiero Di Leva; Luciano Cascione; Ciro Zanca; Brad Bolon; Gerolama Condorelli; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.

Authors:  Luis J Leandro-García; Susanna Leskelä; Carlos Jara; Henrik Gréen; Elisabeth Avall-Lundqvist; Heather E Wheeler; M Eileen Dolan; Lucia Inglada-Perez; Agnieszka Maliszewska; Aguirre A de Cubas; Iñaki Comino-Méndez; Veronika Mancikova; Alberto Cascón; Mercedes Robledo; Cristina Rodríguez-Antona
Journal:  Clin Cancer Res       Date:  2012-06-20       Impact factor: 12.531

6.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

7.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Authors:  Michela Garofalo; Gianpiero Di Leva; Giulia Romano; Gerard Nuovo; Sung-Suk Suh; Apollinaire Ngankeu; Cristian Taccioli; Flavia Pichiorri; Hansjuerg Alder; Paola Secchiero; Pierluigi Gasparini; Arianna Gonelli; Stefan Costinean; Mario Acunzo; Gerolama Condorelli; Carlo Maria Croce
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

8.  The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).

Authors:  Paul A Basciano; James Bussel; Zeeshan Hafeez; Paul J Christos; Paraskevi Giannakakou
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

9.  Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.

Authors:  James B Bussel; Christina S Lee; Caroline Seery; Allison A Imahiyerobo; Michaela V Thompson; Diane Catellier; Ithamar G Turenne; Vivek L Patel; Paul A Basciano; Rebecca L Elstrom; Waleed Ghanima
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

Review 10.  Tubulin proteomics: towards breaking the code.

Authors:  Pascal Verdier-Pinard; Eddy Pasquier; Hui Xiao; Berta Burd; Claude Villard; Daniel Lafitte; Leah M Miller; Ruth H Angeletti; Susan Band Horwitz; Diane Braguer
Journal:  Anal Biochem       Date:  2008-09-18       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.